Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
ADC Therapeutics
Pharma
ADC touts early Zynlonta results in marginal zone lymphoma
ADC Therapeutics provided several updates Monday, including that it's raising $105 million through a sale of common shares and pre-funded warrants.
Eric Sagonowsky
May 6, 2024 4:19pm
Samsung Biologics, LegoChem link to propel ADC development
Feb 7, 2024 10:16am
Vyvanse, Keytruda-Lenvima, Adagene-ADC—Fierce Pharma Asia
Sep 1, 2023 8:50am
ADC Therapeutics scraps Zynlonta study after FDA partial hold
Jul 21, 2023 11:13am
ADC pauses Zynlonta study after 7 patient deaths
Jul 11, 2023 12:23pm
Samsung ready to kick off construction of $1.5B Plant 5
Mar 17, 2023 11:00am
